Althea has acquired Tricycle Day to enhance psychedelic education and access as the industry grows in the United States.
Information on the Target
Althea, a public benefit company focused on establishing infrastructure for regulated psychedelic therapy, has announced its acquisition of Tricycle Day, the foremost independent newsletter dedicated to psychedelic education. This strategic move unites two organizations with a shared mission: assisting individuals in navigating psychedelic care responsibly and effectively.
Tricycle Day, founded by esteemed writer and analyst Henry Winslow, is a trusted source for psychedelic education, reaching tens of thousands of readers weekly. Under this acquisition, Winslow will take on the role of President at Althea, guiding consumer education and demand strategies while maintaining his editorial leadership at Tricycle Day.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The landscape for psychedelic therapy in the United States is evolving rapidly, with increasing legalization and state regulation. Notably, Colorado and Oregon currently operate state-regulated psilocybin progra
Similar Deals
Gannet BioChem → Laysan Bio
2026
Boston Scientific Corporation → Valencia Technologies Corporation
2026
Edwards Lifesciences → JenaValve Technology
2026
Shelter Real Estate Investment Strategies and Calson Management → Atria Park of San Mateo
2026
Althea
invested in
Tricycle Day
in 2026
in a Other deal